https://www.selleckchem.com/pr....oducts/itacitinib-in
ettage with use of hydrogen peroxide as adjuvant and filling up the defect with bone substitute leads to low recurrence rates. Chondroblastoma represents a rare pathology. Therapeutically an aggressive intralesional curettage with use of hydrogen peroxide as adjuvant and filling up the defect with bone substitute leads to low recurrence rates.[This corrects the article DOI 10.1016/j.mmcr.2018.09.007.][This corrects the article DOI 10.1016/j.mmcr.2019.12.011.][This corrects the article DOI 10.1016/j.mmcr.2019.09.002.].[This
Like
Comment
Share
